Investor Relations

Zenabis Presentation

Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations

Zenabis Management Circular

Download Presentation

Zenabis Management Discussion and Analysis

Download Presentation

Zenabis Financial Statements

Download Presentation
Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Press Releases

Zenabis Closes $30 Million Non-Dilutive Financing via Supply Agreement with Tilray®

Thursday July 11, 2019
Zenabis Closes $30 Million Non-Dilutive Financing via Supply Agreement with Tilray®   Vancouver, British Columbia – July 11, 2019 – Zenabis Global…
Read More

Zenabis Submits Site Evidence Package to Health Canada for Langley Facility

Tuesday July 9, 2019
Zenabis Submits Site Evidence Package to Health Canada for Langley Facility   Vancouver, British Columbia – July 9, 2019 – Zenabis Global…
Read More

Zenabis Announces Closing of Previously Announced Amendment and Extension of $25 Million Credit Facility

Monday July 8, 2019
Zenabis Announces Closing of Previously Announced Amendment and Extension of $25 Million Credit Facility VANCOUVER, July 8, 2019 - Zenabis Global Inc.…
Read More

Zenabis Arranges $30 Million Non-Dilutive Financing via Supply Agreement with Tilray®

Tuesday July 2, 2019
Zenabis Arranges $30 Million Non-Dilutive Financing via Supply Agreement with Tilray® Vancouver, British Columbia – July 2, 2019 – Zenabis Global Inc.…
Read More

Zenabis Announces Amendment and Extension of $25 Million Credit Facility

Tuesday July 2, 2019
Zenabis Announces Amendment and Extension of $25 Million Credit Facility VANCOUVER, July 2, 2019  – Further to its press release of February…
Read More

Zenabis Global Inc. Announces Results of Annual General and Special Meeting

Wednesday June 26, 2019
ZENABIS GLOBAL INC. ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING Vancouver, British Columbia – June 26, 2019 – Zenabis Global Inc.…
Read More

IRS Form 8937 (US Investor Tax Information)

Issuers of corporate securities are required to complete Internal Revenue Service Form 8937 to report organizational actions, including distributions and reorganizations that affect the basis of the securities involved in the organizational action. The tax information contained herein is provided for informational purposes only and should not be construed as legal or tax advice. Zenabis does not provide legal or tax advice. Please consult your personal tax advisor for assistance as to how this information will impact your specific tax situation.

Download Form

Board Policies

The high standards expected of Zenabis Global Inc., officers, and directors are put in place by the Board of Directors and reflect their core values regarding sound corporate governance. Most prominently reflected in them is an understanding of how the fiduciary responsibility the Company has to shareholders receives as much emphasis as the effective and forward-thinking management of company business. The following guidelines details standards and procedures that are in line with this dual-focus approach to operating the company catering to both interests equally. Do note that they may be amended when and as necessary based on the Company's interests or to be in accordance with applicable laws and regulations.

Get the Investor Newsletter

Want to keep in touch? We'll send you our latest updates. You can unsubscribe at any time.

Consent